SYT12 plays a critical role in oral cancer and may be a novel therapeutic target

10Citations
Citations of this article
17Readers
Mendeley users who have this article in their library.

Abstract

Synaptotagmin12 (SYT12) has been well characterized as the regulator of transmitter release in the nervous system, however the relevance and molecular mechanisms of SYT12 in oral squamous cell carcinoma (OSCC) are not understood. In the current study, we investigated the expression of SYT12 and its molecular biological functions in OSCC by quantitative reverse transcriptase polymerase chain reaction, immunoblot analysis, and immunohistochemistry. SYT12 were up-regulated significantly in OSCC-derived cell lines and primary OSCC tissue compared with the normal counterparts (P<0.05) and the SYT12 expression levels were correlated significantly with clinical indicators, such as the primary tumoral size, lymph node metastasis, and TNM stage (P<0.05). SYT12 knockdown OSCC cells showed depressed cellular proliferation, migration, and invasion with cell cycle arrest at G1 phase. Surprisingly, we found increased calcium/calmodulin-dependent protein kinase 2 (CAMK2) inhibitor 1 (CAMK2N1) and decreased CAMK2-phosphorylation in the knockdown cells. Furthermore, treatment with L-3, 4-dihydroxyphenylalanine (L-dopa), a drug approved for Parkinson’s disease, led to down-regulation of SYT12 and similar phenotypes to SYT12 knockdown cells. Taken together, we concluded that SYT12 plays a significant role in OSCC progression via CAMK2N1 and CAMK2, and that L-dopa would be a new drug for OSCC treatment through the SYT12 expression.

References Powered by Scopus

Global cancer statistics

31577Citations
N/AReaders
Get full text

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

14279Citations
N/AReaders
Get full text

Autophosphorylation at Thr<sup>286</sup> of the α calcium-calmodulin kinase II in LTP and learning

933Citations
N/AReaders
Get full text

Cited by Powered by Scopus

The dysregulated expression and functional effect of CaMK2 in cancer

25Citations
N/AReaders
Get full text

Establishment of an immune microenvironment-based prognostic predictive model for gastric cancer

9Citations
N/AReaders
Get full text

Chromosome-level genome assembly and population genomics of Mongolian racerunner (Eremias argus) provide insights into high-altitude adaptation in lizards

7Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Eizuka, K., Nakashima, D., Oka, N., Wagai, S., Takahara, T., Saito, T., … Uzawa, K. (2019). SYT12 plays a critical role in oral cancer and may be a novel therapeutic target. Journal of Cancer, 10(20), 4913–4920. https://doi.org/10.7150/jca.32582

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 5

83%

Researcher 1

17%

Readers' Discipline

Tooltip

Medicine and Dentistry 3

43%

Neuroscience 2

29%

Social Sciences 1

14%

Agricultural and Biological Sciences 1

14%

Save time finding and organizing research with Mendeley

Sign up for free